Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NERV Minerva Neurosciences

休市中 10-16 16:00:00 EDT

2.35

-0.07

-2.89%

盘后2.35

+0.000.00%

19:30 EDT

最高2.47	最低2.30	成交量8.56万
今开2.42	昨收2.42	日振幅7.02%
总市值1.12亿	流通市值8,061万	总股本4,775万
成交额20.14万	换手率0.25%	流通股本3,430万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NERV","market":"US","secType":"STK","nameCN":"Minerva Neurosciences","latestPrice":2.35,"timestamp":1792180800000,"preClose":2.42,"halted":0,"volume":85598,"hourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"19:30 EDT","volume":120,"amount":281.96,"timestamp":1792193404116,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02892561983471068,"floatShares":34300100,"shares":47747559,"eps":-28.4557,"marketStatus":"休市中","change":-0.07,"latestTime":"10-16 16:00:00 EDT","open":2.42,"high":2.47,"low":2.3,"amount":201393.69043,"amplitude":0.070248,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-28.4557,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1404187200000,"exchange":"NASDAQ","adjPreClose":2.42,"postHourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"19:30 EDT","volume":120,"amount":281.96,"timestamp":1792193404116,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4881389727519833,"impliedVol":1.0158,"impliedVolPercentile":0.7581},"requestUrl":"/m/hq/s/NERV","defaultTab":"news","newsList":[{"id":"1175262978","title":"Minerva Neurosciences成立科学顾问委员会，以推进Roluperidone及未来管线项目开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1175262978","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175262978?lang=zh_cn&edition=full","pubTime":"2026-06-02 04:09","pubTimestamp":1780344559,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences宣布成立科学顾问委员会，旨在加速其核心候选药物Roluperidone的研发进程，并为公司未来的管线项目提供战略指导。此举标志着该公司在强化其神经科学领域研发实力方面迈出了关键一步。科学顾问委员会的成立将汇聚该领域的顶尖专家，他们的专业知识和洞见有望为Roluperidone的临床开发路径提供重要支持，并帮助规划公司长期的产品线布局。通过组建这一高水平的顾问团队，Minerva Neurosciences期望能更有效地推进其治疗方案的开发，最终为患者带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179986858","title":"Minerva Neurosciences 计划通过 Leerink Partners 发行并出售至多7500万美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1179986858","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179986858?lang=zh_cn&edition=full","pubTime":"2026-05-28 04:16","pubTimestamp":1779912979,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，生物制药公司 Minerva Neurosciences 计划通过投资银行 Leerink Partners 进行普通股的公开发行，筹资总额最高可达7500万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187770397","title":"Minerva Neurosciences宣布全球三期确证性试验完成首例患者筛选，评估Roluperidone治疗精神分裂症阴性症状","url":"https://stock-news.laohu8.com/highlight/detail?id=1187770397","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187770397?lang=zh_cn&edition=full","pubTime":"2026-04-01 04:06","pubTimestamp":1774987584,"startTime":"0","endTime":"0","summary":"生物制药公司Minerva Neurosciences近日披露，其针对精神分裂症阴性症状的创新疗法Roluperidone已启动全球三期确证性临床试验，并成功完成首例患者筛选。该试验旨在进一步验证Roluperidone对改善患者社交退缩、情感淡漠等核心阴性症状的疗效与安全性。此次进展标志着该药物在应对精神分裂症未满足临床需求方面迈出关键一步，为后续申报上市奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102941713","title":"Minerva Neurosciences 计划通过多次发行募集高达2亿美元证券","url":"https://stock-news.laohu8.com/highlight/detail?id=1102941713","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102941713?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:23","pubTimestamp":1773235420,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）的一份最新文件披露，生物制药公司 Minerva Neurosciences Inc. 可能通过多次证券发行，筹集最高达2亿美元的资金。这一举措旨在为公司的运营和研发活动提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518003352","title":"Minerva Neurosciences, Inc盘中异动 大幅跳水6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518003352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518003352?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:15","pubTimestamp":1741634146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时15分，Minerva Neurosciences, Inc股票出现波动，股价急速下跌6.10%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6302.04%、3861.36%、1023.87%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031546a26aa67f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031546a26aa67f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517369928","title":"Minerva Neurosciences, Inc盘中异动 快速上涨5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517369928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517369928?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:17","pubTimestamp":1741198670,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时17分，Minerva Neurosciences, Inc股票出现异动，股价急速拉升5.06%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为948.37%、305.84%、301.30%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021750989d778e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021750989d778e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516753670","title":"Minerva Neurosciences, Inc盘中异动 急速下挫7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516753670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516753670?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:53","pubTimestamp":1741099982,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时53分，Minerva Neurosciences, Inc股票出现异动，股价大幅跳水7.19%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1138.13%、1114.47%、515.66%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Nutriband Inc C/Wts ，振幅分别为44.32%、37.67%、25.66%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225302abe7f68c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225302abe7f68c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516552277","title":"Minerva Neurosciences, Inc2024财年实现净利润1.44百万美元，同比增加104.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516552277?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:00","pubTimestamp":1740844851,"startTime":"0","endTime":"0","summary":"3月2日，Minerva Neurosciences, Inc公布财报，公告显示公司2024财年净利润为1.44百万美元，同比增加104.80%；其中营业收入为0.00美元，每股基本收益为0.19美元。从资产负债表来看，Minerva Neurosciences, Inc总负债62.84百万美元，其中短期债务0.00美元，资产负债比为0.60，流动比率为7.85。机构评级：截至2025年3月2日，当前有1家机构对Minerva Neurosciences, Inc目标价做出预测，其中目标均价为5.00美元，其中最低目标价为5.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104a259dc8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104a259dc8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193483570","title":"Minerva Neurosciences 2024年第四季度GAAP每股收益$(0.56)优于预期的$(1.05)，截至2024年12月31日现金、现金等价物和受限制现金约为$21.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=1193483570","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193483570?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:50","pubTimestamp":1740487840,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences 报告季度亏损每股$，优于分析师一致预期的每股亏损$，超出达46.67%。相比去年同期每股亏损$，这是增长了52.94%。以上内容来自Benzinga Earnings专栏，原文如下：$Minerva Neurosciences$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 46.67 percent. This is a 52.94 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Minerva Neurosciences 2024年第四季度GAAP每股收益$(0.56)优于预期的$(1.05)，截至2024年12月31日现金、现金等价物和受限制现金约为$21.5M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720695","title":"Minerva Neurosciences, Inc盘中异动 股价大涨8.18%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720695?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409533,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分，Minerva Neurosciences, Inc股票出现波动，股价大幅上涨8.18%。截至发稿，该股报1.97美元/股，成交量570股，换手率0.01%，振幅1.65%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为162.64%、71.17%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230533a2521cea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230533a2521cea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512481379","title":"Minerva Neurosciences, Inc盘中异动 早盘股价大跌6.67%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512481379?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:10","pubTimestamp":1739977820,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时10分，Minerva Neurosciences, Inc股票出现波动，股价急速跳水6.67%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为406.48%、226.94%、107.66%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Allogene Therapeutics, Inc.，振幅分别为207.68%、135.05%、36.97%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231020a24c03ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231020a24c03ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511948896","title":"Minerva Neurosciences, Inc盘中异动 早盘急速下挫6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511948896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511948896?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:47","pubTimestamp":1739544474,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时47分，Minerva Neurosciences, Inc股票出现异动，股价急速跳水6.83%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1808.19%、478.46%、417.03%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422475496231f46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422475496231f46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511052962","title":"Minerva Neurosciences, Inc盘中异动 快速上涨10.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511052962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511052962?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:56","pubTimestamp":1739458561,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时56分，Minerva Neurosciences, Inc股票出现异动，股价快速上涨10.06%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1514.20%、1095.31%、117.93%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为92.30%、73.65%、32.86%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213225601a244b16d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213225601a244b16d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510336855","title":"Minerva Neurosciences, Inc盘中异动 股价大跌8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510336855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510336855?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:41","pubTimestamp":1739288479,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时41分，Minerva Neurosciences, Inc股票出现异动，股价急速下跌8.21%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为1.76%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2709.48%、1077.86%、374.17%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234119961f54ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234119961f54ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510867953","title":"Minerva Neurosciences, Inc盘中异动 临近午盘快速跳水5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510867953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510867953?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:39","pubTimestamp":1739205558,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时39分，Minerva Neurosciences, Inc股票出现波动，股价急速下挫5.40%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2845.96%、1572.12%、1108.17%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211003918988090e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211003918988090e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509747342","title":"Minerva Neurosciences, Inc盘中异动 急速下挫5.82%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509747342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509747342?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:00","pubTimestamp":1738940400,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时00分，Minerva Neurosciences, Inc股票出现波动，股价大幅下跌5.82%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为3164.60%、88.22%、68.62%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、46.71%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207230000a23d29da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207230000a23d29da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509232905","title":"Minerva Neurosciences, Inc盘中异动 急速拉升6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509232905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509232905?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:57","pubTimestamp":1738778239,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时57分，Minerva Neurosciences, Inc股票出现异动，股价大幅上涨6.08%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.99%。其相关个股中，Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4525.68%、2227.44%、1676.85%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为122.81%、99.51%、59.58%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020601572096192a94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020601572096192a94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149284","title":"Minerva Neurosciences, Inc盘中异动 早盘快速跳水5.55%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149284?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:43","pubTimestamp":1738593817,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时43分，Minerva Neurosciences, Inc股票出现波动，股价大幅下挫5.55%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为398.21%、339.91%、183.36%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.，振幅分别为82.67%、50.76%、35.62%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032243379616fdc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032243379616fdc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621679","title":"Minerva Neurosciences, Inc盘中异动 股价大跌5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507621679?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:33","pubTimestamp":1738247608,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时33分，Minerva Neurosciences, Inc股票出现异动，股价快速跳水5.98%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为624.17%、125.64%、104.73%，振幅较大的相关个股有Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Kazia Therapeutics Limited，振幅分别为21.38%、21.31%、19.56%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223328a234558c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223328a234558c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507554386","title":"Minerva Neurosciences, Inc盘中异动 大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507554386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507554386?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:03","pubTimestamp":1738080184,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时03分，Minerva Neurosciences, Inc股票出现波动，股价快速上涨5.06%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Transcode Therapeutics, Inc.涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4069.00%、3150.18%、1862.92%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp，振幅分别为122.16%、102.05%、89.64%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129000304a232822e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129000304a232822e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minervaneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.261},{"period":"1month","weight":-0.3257},{"period":"3month","weight":-0.4496},{"period":"6month","weight":-0.6508},{"period":"1year","weight":-0.0713},{"period":"ytd","weight":-0.4154}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Minerva Neurosciences, Inc.于2007年4月23日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化中枢神经系统疾病的专利候选产品。其主要候选药物罗鲁哌酮正在开发中，用于治疗精神分裂症的阴性症状，计划进行3期确认性试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.082044},{"month":2,"riseRate":0.25,"avgChangeRate":-0.062323},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.006398},{"month":4,"riseRate":0.5,"avgChangeRate":0.052093},{"month":5,"riseRate":0.5,"avgChangeRate":0.114382},{"month":6,"riseRate":0.666667,"avgChangeRate":0.074755},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.056124},{"month":8,"riseRate":0.538462,"avgChangeRate":0.292676},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.023988},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.136329},{"month":11,"riseRate":0.5,"avgChangeRate":0.078313},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.079275}],"exchange":"NASDAQ","name":"Minerva Neurosciences","nameEN":"Minerva Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Minerva Neurosciences,NERV,Minerva Neurosciences股票,Minerva Neurosciences股票老虎,Minerva Neurosciences股票老虎国际,Minerva Neurosciences行情,Minerva Neurosciences股票行情,Minerva Neurosciences股价,Minerva Neurosciences股市,Minerva Neurosciences股票价格,Minerva Neurosciences股票交易,Minerva Neurosciences股票购买,Minerva Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}